Theme | Transition to the MDR and IVDR |
Target Audience | Notified Bodies (NB), Manufacturers |
Products concerned | MD & IVD |
Documents mentioned |
Regulation (EU) 2017/745 Regulation (EU) 2017/746 MDCG 2019-6 MDCG 2020-12 MDCG 2022-4 MDCG 2022-11 |
This document, published in August 2022, outlines actions to improve the efficiency of the implementation of regulatory requirements to avoid disruption of supply of IVD and MD. Actions are proposed to address 3 major challenges: increasing NB capacity, improving access to NB, and improving manufacturer preparedness.